The IL-1RI co-receptor TILRR (FREM1 isoform 2) controls aberrant inflammatory responses and development of vascular disease

Smith, S.A., Samokhin, A.O., Alfadi, M. et al. (7 more authors) (2017) The IL-1RI co-receptor TILRR (FREM1 isoform 2) controls aberrant inflammatory responses and development of vascular disease. JACC: Basic to Translational Science, 2 (4). pp. 398-414.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY 4.0 LICENSE ( http://creativecommons.org/licenses/by/4.0/ ) .
Keywords: heparan sulfate proteoglycan; interleukin-1 receptor; IL-1RI; NF-κB; TILRR
Dates:
  • Published: August 2017
  • Published (online): 28 August 2017
  • Accepted: 29 March 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Cardiovascular Science (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
BRITISH HEART FOUNDATIONPG/11/103/29219
BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL (BBSRC)BB/J009687/1
Depositing User: Symplectic Sheffield
Date Deposited: 05 Sep 2017 15:21
Last Modified: 23 Oct 2018 13:56
Published Version: https://doi.org/10.1016/j.jacbts.2017.03.014
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jacbts.2017.03.014

Share / Export

Statistics